dc.contributor.author | Palomar-Cros, Anna | |
dc.contributor.author | Straif, Kurt | |
dc.contributor.author | Romaguera, Dora | |
dc.contributor.author | Aragonés, Nuria | |
dc.contributor.author | Castaño-Vinyals, Gemma | |
dc.contributor.author | Martin, Vicente | |
dc.contributor.author | Moreno, Victor | |
dc.contributor.author | Gómez-Acebo, Inés | |
dc.contributor.author | Guevara, Marcela | |
dc.contributor.author | Aizpurua, Amaia | |
dc.contributor.author | Molina-Barceló, Ana | |
dc.contributor.author | Jiménez-Moleón, José-Juan | |
dc.contributor.author | Tardón, Adonina | |
dc.contributor.author | Contreras-Llanes, Manuel | |
dc.contributor.author | Marcos-Gragera, Rafael | |
dc.contributor.author | Huerta, José Mª | |
dc.contributor.author | Perez-Gomez, Beatriz | |
dc.contributor.author | Espinosa, Ana | |
dc.contributor.author | Hernández-Segura, Natalia | |
dc.contributor.author | Obón-Santacana, Mireia | |
dc.contributor.author | Alonso-Molero, Jéssica | |
dc.contributor.author | Burgui, Rosana | |
dc.contributor.author | Amiano, Pilar | |
dc.contributor.author | Pinto-Carbó, Marina | |
dc.contributor.author | Olmedo-Requena, Rocío | |
dc.contributor.author | Fernández-Tardón, Guillermo | |
dc.contributor.author | Santos-Sánchez, Vanessa | |
dc.contributor.author | Fernandez de Larrea-Baz, Nerea | |
dc.contributor.author | Fernández-Villa, Tania | |
dc.contributor.author | Casabonne, Delphine | |
dc.contributor.author | Dierssen-Sotos, Trinidad | |
dc.contributor.author | Ardanaz, Eva | |
dc.contributor.author | Dorronsoro, Ane | |
dc.contributor.author | Pollan-Santamaria, Marina | |
dc.contributor.author | Kogevinas, Manolis | |
dc.contributor.author | Lassale, Camille | |
dc.date.accessioned | 2023-08-22T12:39:37Z | |
dc.date.available | 2023-08-22T12:39:37Z | |
dc.date.issued | 2023-09-01 | |
dc.identifier.citation | Int J Cancer. 2023 Sep 1;153(5):979-993. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/16328 | |
dc.description.abstract | Use of artificial sweeteners (AS) such as aspartame, cyclamate, saccharin and sucralose is widespread. We evaluated the association of use of aspartame and other AS with cancer. In total 1881 colorectal, 1510 breast, 972 prostate and 351 stomach cancer and 109 chronic lymphocytic leukaemia (CLL) cases and 3629 population controls from the Spanish Multicase-Control (MCC-Spain) study were recruited (2008-2013). The consumption of AS, from table-top sweeteners and artificially sweetened beverages, was assessed through a self-administered and validated food frequency questionnaire (FFQ). Sex-specific quartiles among controls were determined to compare moderate consumers (<third quartile) and high consumers (≥ third quartile) vs non consumers (reference category), distinguishing aspartame-containing products and other AS. Unconditional logistic regression models were used to estimate adjusted OR and 95%CI, and results were stratified by diabetes status. Overall, we found no associations between the consumption of aspartame or other AS and cancer. Among participants with diabetes, high consumption of other AS was associated with colorectal cancer (OR = 1.58, 95% CI 1.05-2.41, P trend = .03) and stomach cancer (OR = 2.27 [0.99-5.44], P trend = .06). High consumption of aspartame, was associated with stomach cancer (OR = 2.04 [0.7-5.4], P trend = .05), while a lower risk was observed for breast cancer (OR = 0.28 [0.08-0.83], P trend = .03). In some cancers, the number of cases in participants with diabetes were small and results should be interpreted cautiously. We did not find associations between use of AS and cancer, but found associations between high consumption of aspartame and other AS and different cancer types among participants with diabetes. | es_ES |
dc.description.sponsorship | The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078-Huelva, PS09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI17CIII/00034), by the Fundación Marqués de Valdecilla (API 10/09), by the ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad [MINECO] through the Instituto de Salud Carlos III [ISCIII] and Red Temática de Investigación del Cáncer [RTICC] del ISCIII [RD12/0036/0036]), by the Junta de Castilla y León (LE22A10-2), by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the Recercaixa (2010ACUP 00310), by the Regional Government of the Basque Country, by the Consejería de Sanidad de la Región de Murcia, by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723, 2014SGR850, 2017SGR1085, 2021SGR01354 by the Fundación Caja de Ahorros de Asturias and by the University of Oviedo. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Anna Palomar-Cros is supported by a MINECO (Spanish Ministry of Economy) fellowship (PRE2019-089038). Camille Lassale is supported by a Ramon y Cajal Fellowship RYC2020-029599 funded by MCIN (Spanish Ministry of Science and Innovation) and EI FSE “Invest in your future”. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Artificial sweeteners | es_ES |
dc.subject | Aspartame | es_ES |
dc.subject | Cancer risk | es_ES |
dc.subject | Case-control | es_ES |
dc.subject.mesh | Stomach Neoplasms | es_ES |
dc.subject.mesh | Diabetes Mellitus | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Sweetening Agents | es_ES |
dc.subject.mesh | Aspartame | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.title | Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain) | es_ES |
dc.type | research article | es_ES |
dc.rights.license | Atribución-NoComercial 4.0 Internacional | * |
dc.identifier.pubmedID | 37323037 | es_ES |
dc.format.volume | 153 | es_ES |
dc.format.number | 5 | es_ES |
dc.format.page | 979-993 | es_ES |
dc.identifier.doi | 10.1002/ijc.34577 | es_ES |
dc.contributor.funder | Government of Catalonia (España) | es_ES |
dc.contributor.funder | Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) | es_ES |
dc.contributor.funder | Regional Government of Andalusia (España) | es_ES |
dc.contributor.funder | Gobierno de la Región de Murcia (España) | es_ES |
dc.contributor.funder | Generalitat Valenciana (España) | es_ES |
dc.contributor.funder | Unión Europea. Comisión Europea | es_ES |
dc.contributor.funder | Fundación Caja de Ahorros de Asturias | es_ES |
dc.contributor.funder | Fundación Marqués de Valdecilla | es_ES |
dc.contributor.funder | International Cancer Genome Consortium | es_ES |
dc.contributor.funder | Junta de Castilla y León (España) | es_ES |
dc.contributor.funder | Ministerio de Economía (España) | es_ES |
dc.contributor.funder | Basque Government (España) | es_ES |
dc.contributor.funder | Asociación Española Contra el Cáncer | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | es_ES |
dc.contributor.funder | Red Temática de Investigación Cooperativa en Cáncer (RTICC) (España) | es_ES |
dc.contributor.funder | Fundación La Caixa | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | es_ES |
dc.contributor.funder | University of Oviedo (España) | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1097-0215 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1002/ijc.34577 | es_ES |
dc.identifier.journal | International journal of cancer | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/CE/FOOD-CT-2006-036224-HIWATE | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD12%2F0036%2F0036/ES/Cáncer/ | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CEX2018-000806-S | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PRE2019-089038 | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RYC2020-029599 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI08/1770 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI08/0533 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI08/1359 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PS09/00773-Cantabria | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PS09/01286-León | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PS09/01903-Valencia | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PS09/02078-Huelva | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PS09/01662-Granada | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2011) (2011)/PI11/01403 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI11/01889-FEDER | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2011) (2011)/PI11/00226 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2011) (2011)/PI11/01810 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2011) (2011)/PI11/02213 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2012) (2012)/PI12/00488 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2012) (2012)/PI12/00265 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2012) (2012)/PI12/01270 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2012) (2012)/PI12/00715 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2012) (2012)/PI12/00150 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2014). Modalidad proyectos en salud. (2014)/PI14/01219 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI14/0613 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2015). Modalidad proyectos en salud. (2015)/PI15/00069 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2015). Modalidad proyectos en salud. (2015)/PI15/00914 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2015). Modalidad proyectos en salud. (2015)/PI15/01032 | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI17-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2017)/PI17CIII/00034 | es_ES |